L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

NCT07227350 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Basal Cell Carcinoma

Interventions

DRUG: L19IL2
DRUG: L19TNF
DRUG: L19IL2/L19TNF

Sponsor

Philogen S.p.A.